跳至主要内容
临床试验/EUCTR2011-003115-34-AT
EUCTR2011-003115-34-AT进行中(未招募)1 期

A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles after Pelvic Lymphadenectomy in Women with Gynecologic Malignancies: a Randomized Clinical Trial - Tachosil for Prevention of Symptomatic Lymphoceles after pelvic lymphadenectomy

Medizinische Universität Wien0 个研究点目标入组 140 人开始时间: 2012年5月22日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Women undergoing open or laparoscopic surgery for cervical or endometrial cancer
  • -Age between 18 and 70 yrs
  • -Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • -Women with previously diagnosed lymph edema
  • -Known disease of the lymphatic system
  • -Immunocompromised women such as those with an immunosuppressive medication or a known disease of the immune system

研究者

相似试验